A Placebo-Controlled Trial of Obeticholic Acid in Primary Biliary Cholangitis

Autor: Nevens, F, Andreone, P, Mazzella, G, Strasser, S, Bowlus, C, Drenth, J, Pockros, P, Regula, J, Beuers, U, Trauner, M, Jones, D, Floreani, A, Hohenester, S, Luketic, V, Shiffman, M, van Erpecum, K, Vargas, V, Vincent, C, Hirschfield, G, Shah, H, Hansen, B, Lindor, K, Marschall, H, Kowdley, K, Hooshmand Rad, R, Marmon, T, Sheeron, S, Pencek, R, Macconell, L, Pruzanski, M, Shapiro, D. Collaborator: Carbone, INVERNIZZI, PIETRO

Publikováno v: New England Journal of Medicine, 375(7), 631-643. Massachussetts Medical Society
New England journal of medicine, 375(7), 631-643. Massachussetts Medical Society
New England Journal of Medicine, 375(7), 631. Massachussetts Medical Society
The New England Journal of Medicine, 375, 631-43
The New England Journal of Medicine, 375, 7, pp. 631-43

none 32 BACKGROUND Primary biliary cholangitis (formerly called primary biliary cirrhosis) can progress to cirrhosis and death despite ursodiol therapy. Alkaline phosphatase and bilirubin levels correlate with the risk of liver transplantation or dea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c1282490c2e4da3e25822cd675fd58e
https://doi.org/10.1056/nejmoa1509840

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

SAT-357 - Mitigation of Pruritus during Obeticholic Acid Treatment in Patients with Primary Biliary Cirrhosis: Strategies and Successes

Autor: Mayo, M.J., Kremer, A., Beuers, U., Marmon, T., Hooshmand-Rad, R., Pencek, R., Shapiro, D.

Publikováno v: In Journal of Hepatology 2016 64(2) Supplement:S636-S637

THU-487 - A Multicenter, Randomized, Open Label, Single- and Multiple-Dose, Dose Finding Study and Open-Label Extension to Assess the Effects of Obeticholic Acid in Pediatric Patients with Biliary Atresia

Autor: Karpen, S., Eliot, L., Scholz, B., Joshi, M.M., Merrigan, M.M., Sciacca, C., Marmon, T., Hooshmand-Rad, R., MacConell, L., Shapiro, D.

Publikováno v: In Journal of Hepatology 2016 64(2) Supplement:S294-S294

P1321 : A phase 3B, double blind, placebo controlled study evaluating the effect of obeticholic acid on clinical outcomes in subjects with primary biliary cirrhosis at elevated risk of progression to liver transplant or death

Autor: Lindor, K., Hansen, B., Pencek, R., Hooshmand-Rad, R., Marmon, T., MacConell, L., Shapiro, D., Jones, D.

Publikováno v: In Journal of Hepatology April 2015 62 Supplement 2:S850-S851